Familial Primary Pulmonary Hypertension - 25 Studies Found

Recruiting : National Cohort Study of Idiopathic and Heritable Pulmonary Arterial Hypertension
: Pulmonary Arterial Hypertension
: 2013-07-08
Recruiting : Hormonal, Metabolic, and Signaling Interactions in PAH
:
  • Idiopathic Pulmonary Arterial Hypertension
  • Heritable Pulmonary Arteria
    : 2013-01-15
Recruiting : Efficacy Study of Cardizem in Pulmonary Arterial Hypertension
:
  • Idiopathic Pulmonary Arterial Hypertension
  • Primary Pulmonary Hypertension
  • Drug: Diltiazem Hydrochloride

Not yet recruiting : A Mobile Health Intervention in Pulmonary Arterial Hypertension
:
  • Pulmonary Arterial Hypertension
  • Idiopathic Pulmonary Arterial Hypertension
  • Device: Smartphone Text Messaging

Not yet recruiting : ALlogeneic Cardiosphere-derived Stem Cells (CDCs) for Pulmonary Hypertension therApy
: Pulmonary Arterial Hypertension (PAH)
: 2017-05-02
:
  • Biological: Allogeneic Human Cardiosphere-Derived Stem Cells

Recruiting : Repeatability of OCT and IV-US in Pulmonary Arterial Hypertension
: Pulmonary Arterial Hypertension
: 2017-04-04
: Procedure: Patients with Pulmonary Arterial Hypertension 2 repeated measurement session to enable assess
Not yet recruiting : Effect of Selexipag on Daily Life Physical Activity of Patients With Pulmonary Arterial Hypertension.
: Pulmonary Arterial Hypertension
: 2017-03-06
:
  • Drug: Selexipag Film-coated ta
Recruiting : Pilot Study of the Safety and Efficacy of Anakinra in Pulmonary Arterial Hypertension
: Pulmonary Arterial Hypertension
: 2016-05-04
: Drug: Anakinra Other Name: Kineret
Completed : TRUST-2: Safety and Efficacy of Intravenous Remodulin® in Patients in India With Pulmonary Arterial Hypertension (PAH)
: Pulmonary Arterial Hypertension
: 2017-02-09
: Drug: Remodulin® (Intravenous Treprostinil) Intravenous treprostinil supplied in 20-mL vials and di
Not yet recruiting : Impact of Rehabilitation Program on PAH Patients Treated With Macitentan.
: Pulmonary Arterial Hypertension
: 2017-02-05
: Other: Exercise program patients who are stable on Macitentan therapy (received in both groups before en
Next >>>